Follow
Vasile Enrico
Vasile Enrico
Verified email at ao-pisa.toscana.it
Title
Cited by
Cited by
Year
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity
E Giovannetti, N Funel, GJ Peters, M Del Chiaro, LA Erozenci, E Vasile, ...
Cancer research 70 (11), 4528-4538, 2010
5302010
Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by …
G Masi, F Loupakis, L Pollina, E Vasile, S Cupini, S Ricci, IM Brunetti, ...
Annals of surgery 249 (3), 420-425, 2009
3192009
Correlation of CDA, ERCC1, and XPD polymorphisms with response and survival in gemcitabine/cisplatin–treated advanced non–small cell lung cancer patients
C Tibaldi, E Giovannetti, E Vasile, V Mey, AC Laan, S Nannizzi, ...
Clinical cancer research 14 (6), 1797-1803, 2008
2722008
Randomized trial of two induction chemotherapy regimens in metastatic colorectal cancer: an updated analysis
G Masi, E Vasile, F Loupakis, S Cupini, L Fornaro, G Baldi, L Salvatore, ...
Journal of the National Cancer Institute 103 (1), 21-30, 2011
2302011
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
M Del Re, R Marconcini, G Pasquini, E Rofi, C Vivaldi, F Bloise, ...
British journal of cancer 118 (6), 820-824, 2018
2242018
Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and outcomes with nivolumab in pretreated non-small cell lung cancer (NSCLC): a large retrospective …
A Russo, M Russano, T Franchina, MR Migliorino, G Aprile, G Mansueto, ...
Advances in therapy 37, 1145-1155, 2020
1312020
The good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms
S Caponi, N Funel, AE Frampton, F Mosca, L Santarpia, ...
Annals of oncology 24 (3), 734-741, 2013
1192013
HER2 loss in HER2‐positive gastric or gastroesophageal cancer after trastuzumab therapy: implication for further clinical research
F Pietrantonio, M Caporale, F Morano, M Scartozzi, A Gloghini, F De Vita, ...
International journal of cancer 139 (12), 2859-2864, 2016
1142016
Natural history of non-small-cell lung cancer with bone metastases
D Santini, S Barni, S Intagliata, A Falcone, F Ferrał, D Galetta, L Moscetti, ...
Scientific reports 5 (1), 1-9, 2015
1122015
Anti-HER agents in gastric cancer: from bench to bedside
L Fornaro, M Lucchesi, C Caparello, E Vasile, S Caponi, L Ginocchi, ...
Nature reviews Gastroenterology & hepatology 8 (7), 369-383, 2011
1122011
Role of CYB5A in pancreatic cancer prognosis and autophagy modulation
E Giovannetti, Q Wang, A Avan, N Funel, T Lagerweij, JH Lee, V Caretti, ...
Journal of the National Cancer Institute 106 (1), djt346, 2014
1102014
Contribution of KRAS mutations and c. 2369C> T (p. T790M) EGFR to acquired resistance to EGFR-TKIs in EGFR mutant NSCLC: a study on circulating tumor DNA
M Del Re, M Tiseo, P Bordi, A D'Incecco, A Camerini, I Petrini, M Lucchesi, ...
Oncotarget 8 (8), 13611, 2017
952017
FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
C Caparello, LL Meijer, I Garajova, A Falcone, TY Le Large, N Funel, ...
World journal of gastroenterology 22 (31), 6987, 2016
932016
High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer
E Giovannetti, A Van Der Velde, N Funel, E Vasile, V Perrone, LG Leon, ...
PloS one 7 (11), e49145, 2012
932012
Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center
G Brandi, M Venturi, MA Pantaleo, G Ercolani, L Fornaro, N Silvestris, ...
Digestive and Liver Disease 48 (3), 231-241, 2016
922016
Italian nivolumab expanded access program in nonsquamous non–small cell lung cancer patients: results in never-smokers and EGFR-mutant patients
MC Garassino, AJ Gelibter, F Grossi, R Chiari, HS Parra, S Cascinu, ...
Journal of Thoracic Oncology 13 (8), 1146-1155, 2018
852018
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
L Fornaro, S Cereda, G Aprile, S Di Girolamo, D Santini, N Silvestris, ...
British journal of cancer 110 (9), 2165-2169, 2014
832014
Baseline elevated leukocyte count in peripheral blood is associated with poor survival in patients with advanced non-small cell lung cancer: a prognostic model
C Tibaldi, E Vasile, I Bernardini, C Orlandini, M Andreuccetti, A Falcone
Journal of cancer research and clinical oncology 134, 1143-1149, 2008
802008
Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer
M Del Re, C Vivaldi, E Rofi, E Vasile, M Miccoli, C Caparello, ...
Scientific reports 7 (1), 7931, 2017
792017
Correlation between cytidine deaminase genotype and gemcitabine deamination in blood samples
E Giovannetti, AC Laan, E Vasile, C Tibaldi, S Nannizzi, S Ricciardi, ...
Nucleosides, Nucleotides, and Nucleic Acids 27 (6-7), 720-725, 2008
682008
The system can't perform the operation now. Try again later.
Articles 1–20